Syn bio firm raises half a billion in IPO
In California, synthetic biology firm Zymergen has raised $500 million in an initial public offering. Shares began trading Thursday on Nasdaq under the ticker ZY. The company sold 16.1 million shares at $31/share, giving it an enterprise value of $3.2 billion. The company had expected to sell 13.6 million shares for $28-$31/share. The company reported […]











